The ins and outs of small GTPase Rac1 in the vasculature

Journal of Pharmacology and Experimental Therapeutics

Volumn 354, Issue 2, 2015, Pages 91-102

  Marinković, Goran ^a   Heemskerk, Niels ^a   Van Buul, Jaap D ^a   De Waard, Vivian ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN CDC42; RAC1 PROTEIN; RAS PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RHO FACTOR; VASCULAR CELL ADHESION MOLECULE 1; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RAC1 PROTEIN, HUMAN;

ADVENTITIA; BLOOD VESSEL WALL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELLS BY BODY ANATOMY; CROSS LINKING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; FIBROSIS; INTRACELLULAR SIGNALING; MOUSE; MULTIGENE FAMILY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; BLOOD VESSEL; CELL MOTION; CYTOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSELS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; MONOMERIC GTP-BINDING PROTEINS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RAC1 GTP-BINDING PROTEIN;

EID: 84941552868     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.115.223610     Document Type: Review

References (142)

1. Adam O, Frost G, Custodis F, Sussman MA, Schäfers HJ, Böhm M, and Laufs U (2007) Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 50: 359-367.
2. Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S, Sussman MA, Rosenkranz S, Kroemer HK, Schäfers HJ, et al. (2010) Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol 55:469-480.
3. Adamson RH, Sarai RK, Altangerel A, Thirkill TL, Clark JF, and Curry FR (2010) Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. Cardiovasc Res 88:344-351.
4. Adiarto S, Heiden S, Vignon-Zellweger N, Nakayama K, Yagi K, Yanagisawa M, and Emoto N (2012) ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. Life Sci 91:651-657.
5. Ahmad M, Zhang Y, Zhang Y, Papharalambus C, and Alexander RW (2002) Role of isoprenylcysteine carboxyl methyltransferase in tumor necrosis factor-alpha stimulation of expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol 22:759-764.
6. Ambriz-Peña X, García-Zepeda EA, Meza I, and Soldevila G (2014) Jak3 enables chemokine-dependent actin cytoskeleton reorganization by regulating cofilin and Rac/Rhoa GTPases activation. PLoS ONE 9:e88014.
7. Antonopoulos AS, Margaritis M, Lee R, Channon K, and Antoniades C (2012) Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 18:1519-1530.
8. Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L, Molango S, Heitz F, Merlot C, Szyndralewiez C, et al. (2012) Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56:2316-2327.
9. Ashino T, Yamamoto M, Yoshida T, and Numazawa S (2013) Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia. Arterioscler Thromb Vasc Biol 33:760-768.
10. Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H, and Sanchez-Madrid F (2002) Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157:1233-1245.
11. Baumer Y, Spindler V, Werthmann RC, Bünemann M, and Waschke J (2009) Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J Cell Physiol 220:716-726.
12. Bazzoni G (2006) Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost 95:36-42.
13. Bazzoni G and Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84:869-901.
14. Bedard K and Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245-313.
15. Bid HK, Roberts RD, Manchanda PK, and Houghton PJ (2013) RAC1: An emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol Cancer Ther 12:1925-1934.
16. Blumbach K, Zweers MC, Brunner G, Peters AS, Schmitz M, Schulz JN, Schild A, Denton CP, Sakai T, Fässler R, et al. (2010) Defective granulation tissue formation in mice with specific ablation of integrin-linked kinase in fibroblasts - role of TGFb1 levels and RhoA activity. J Cell Sci 123:3872-3883.
17. Boissier P and Huynh-Do U (2014) The guanine nucleotide exchange factor Tiam1: A Janus-faced molecule in cellular signaling. Cell Signal 26:483-491.
18. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, and Dejana E (1995) Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol 15:1229-1239.
19. Carlin CM, Peacock AJ, and Welsh DJ (2007) Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 37:447-456.
20. Carman CV and Springer TA (2004) A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 167:377-388.
21. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, et al. (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGFmediated endothelial survival and angiogenesis. Cell 98:147-157.
22. Che ZQ, Gao PJ, Shen WL, Fan CL, Liu JJ, and Zhu DL (2008) Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor. Hypertens Res 31:1233-1240.
23. Chen XL, Zhang Q, Zhao R, and Medford RM (2004) Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: Role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 286:H1001-H1007.
24. Chen JC, Lin BB, Hu HW, Lin C, Jin WY, Zhang FB, Zhu YA, Lu CJ, Wei XJ, and Chen RJ (2014) NGF accelerates cutaneous wound healing by promoting the migration of dermal fibroblasts via the PI3K/Akt-Rac1-JNK and ERK pathways. Biomed Res Int 2014:547187.
25. Cheng C, Tempel D, Den Dekker WK, Haasdijk R, Chrifi I, Bos FL, Wagtmans K, van de Kamp EH, Blonden L, Biessen EA, et al. (2011) Ets2 determines the inflammatory state of endothelial cells in advanced atherosclerotic lesions. Circ Res 109:382-395.
26. Cotton M, Boulay PL, Houndolo T, Vitale N, Pitcher JA, and Claing A (2007) Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration. Mol Biol Cell 18:501-511.
27. Cuadrado A, Martín-Moldes Z, Ye J, and Lastres-Becker I (2014) Transcription factors NRF2 and NF-kB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem 289:15244-15258.
28. Dai Z, Aoki T, Fukumoto Y, and Shimokawa H (2012) Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. J Cardiol 60:416-421.
29. D'Ambrosi N, Rossi S, Gerbino V, and Cozzolino M (2014) Rac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis. Front Cell Neurosci 8:279.
30. Dammanahalli JK and Sun Z (2008) Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: A novel function of ETB1 receptors. Endocrinology 149:4979-4987.
31. Debidda M, Wang L, Zang H, Poli V, and Zheng Y (2005) A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem 280:17275-17285.
32. Douglas G, Bendall JK, Crabtree MJ, Tatham AL, Carter EE, Hale AB, and Channon KM (2012) Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE-/- mice. Cardiovasc Res 94:20-29.
33. Drummond GR and Sobey CG (2014) Endothelial NADPH oxidases: Which NOX to target in vascular disease? Trends Endocrinol Metab 25:452-463.
34. Duan L, Chen G, Virmani S, Ying G, Raja SM, Chung BM, Rainey MA, Dimri M, Ortega-Cava CF, Zhao X, et al. (2010) Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture. J Biol Chem 285:1555-1568.
35. Duran-Prado M, Morell M, Delgado-Maroto V, Castaño JP, Aneiros-Fernandez J, de Lecea L, Culler MD, Hernandez-Cortes P, O'Valle F, and Delgado M(2013) Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Circ Res 112:1444-1455.
36. Elnakish MT, Hassanain HH, Janssen PM, Angelos MG, and Khan M (2013) Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol 231:290-300.
37. Fernandes DC, Manoel AH, Wosniak J Jr, and Laurindo FR (2009) Protein disulfide isomerase overexpression in vascular smooth muscle cells induces spontaneous preemptive NADPH oxidase activation and Nox1 mRNA expression: Effects of nitrosothiol exposure. Arch Biochem Biophys 484:197-204.
38. Ferri N, Contini A, Bernini SK, and Corsini A (2013) Role of small GTPase protein Rac1 in cardiovascular diseases: development of new selective pharmacological inhibitors. J Cardiovasc Pharmacol 62:425-435.
39. Garcia-Mata R, Boulter E, and Burridge K (2011) The 'invisible hand': Regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 12:493-504.
40. Görlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R (2000) A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87:26-32.
41. Gregg D, Rauscher FM, and Goldschmidt-Clermont PJ (2003) Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol 285:C723-C734.
42. Guo AK, Hou YY, Hirata H, Yamauchi S, Yip AK, Chiam KH, Tanaka N, Sawada Y, and Kawauchi K (2014) Loss of p53 enhances NF-kB-dependent lamellipodia formation. J Cell Physiol 229:696-704.
43. Higuchi K, Nakaoka Y, Shioyama W, Arita Y, Hashimoto T, Yasui T, Ikeoka K, Kuroda T, Minami T, Nishida K, et al. (2012) Endothelial Gab1 deletion accelerates angiotensin II-dependent vascular inflammation and atherosclerosis in apolipoprotein E knockout mice. Circ J 76:2031-2040.
44. Hinoki A, Kimura K, Higuchi S, Eguchi K, Takaguri A, Ishimaru K, Frank GD, Gerthoffer WT, Sommerville LJ, Autieri MV, et al. (2010) p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo. Hypertension 55:161-165.
45. Hoang MV, Nagy JA, and Senger DR (2011) Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood 117:1751-1760.
46. Hordijk PL (2006) Regulation of NADPH oxidases: The role of Rac proteins. Circ Res 98:453-462.
47. Hordijk PL, Anthony E, Mul FP, Rientsma R, Oomen LC, and Roos D (1999) Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112:1915-1923.
48. Huh JY, Son DJ, Lee Y, Lee J, Kim B, Lee HM, Jo H, Choi S, Ha H, and Chung MH (2012) 8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation. Free Radic Biol Med 53:109-121.
49. Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, and Hirata Y (2008) Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology 149:1009-1014.
50. Jaiswal M, Dvorsky R, and Ahmadian MR (2013) Deciphering the molecular and functional basis of Dbl family proteins: A novel systematic approach toward classification of selective activation of the Rho family proteins. J Biol Chem 288: 4486-4500.
51. Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CX, and Laurindo FR (2005) Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 280: 40813-40819.
52. Jin Y, Liu Y, Lin Q, Li J, Druso JE, Antonyak MA, Meininger CJ, Zhang SL, Dostal DE, Guan JL, et al. (2013) Deletion of Cdc42 enhances ADAM17-mediated vascular endothelial growth factor receptor 2 shedding and impairs vascular endothelial cell survival and vasculogenesis. Mol Cell Biol 33:4181-4197.
53. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, and Drummond GR (2010) Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol 298:H24-H32.
54. Kalwa H and Michel T (2011) The MARCKS protein plays a critical role in phosphatidylinositol 4, 5-bisphosphate metabolism and directed cell movement in vascular endothelial cells. J Biol Chem 286:2320-2330.
55. Kalwa H, Sartoretto JL, Sartoretto SM, and Michel T (2012) Angiotensin-II and MARCKS: A hydrogen peroxide- And RAC1-dependent signaling pathway in vascular endothelium. J Biol Chem 287:29147-29158.
56. Kanazawa S, Fujiwara T, Matsuzaki S, Shingaki K, Taniguchi M, Miyata S, Tohyama M, Sakai Y, Yano K, Hosokawa K, et al. (2010) bFGF regulates PI3-kinase-Rac1-JNK pathway and promotes fibroblast migration in wound healing. PLoS ONE 5:e12228.
57. Kawarazaki H, Ando K, Shibata S, Muraoka K, Fujita M, Kawarasaki C, and Fujita T (2012) Mineralocorticoid receptor-Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats. J Hypertens 30:1977-1985.
58. Khan OM, Ibrahim MX, Jonsson IM, Karlsson C, Liu M, Sjogren AK, Olofsson FJ, Brisslert M, Andersson S, Ohlsson C, et al. (2011) Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. J Clin Invest 121:628-639.
59. Khan OM, Akula MK, Skålen K, Karlsson C, Ståhlman M, Young SG, Borén J, and Bergo MO (2013) Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice. Circulation 127: 782-790.
60. Kida T, Omori K, Hori M, Ozaki H, and Murata T (2014) Stimulation of G proteincoupled bile acid receptor enhances vascular endothelial barrier function via activation of protein kinase A and Rac1. J Pharmacol Exp Ther 348:125-130.
61. Kim JA, Montagnani M, Koh KK, and Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888-1904.
62. Kimura TE, Duggirala A, Hindmarch CC, Hewer RC, Cui MZ, Newby AC, and Bond M(2014) Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells. J Mol Cell Cardiol 72:9-19.
63. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, and LeBoeuf RC (2000) Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535.
64. Knezevic II, Predescu SA, Neamu RF, Gorovoy MS, Knezevic NM, Easington C, Malik AB, and Predescu DN (2009) Tiam1 and Rac1 are required for plateletactivating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem 284:5381-5394.
65. Komaravolu RK, Adam C, Moonen JR, Harmsen MC, Goebeler M, and Schmidt M (2015) Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1. Cardiovasc Res 105:86-95.
66. Konior A, Schramm A, Czesnikiewicz-Guzik M, and Guzik TJ (2014) NADPH oxidases in vascular pathology. Antioxid Redox Signal 20:2794-2814.
67. Kou R, Sartoretto J, and Michel T (2009) Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulindependent kinase kinase-beta. J Biol Chem 284:14734-14743.
68. Kowanetz M and Ferrara N (2006) Vascular endothelial growth factor signaling pathways: Therapeutic perspective. Clin Cancer Res 12:5018-5022.
69. Koyama T, Ochoa-Callejero L, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Iinuma N, Arai T, Yoshizawa T, Iesato Y, Lei Y, et al. (2013) Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation 127:842-853.
70. Krause M and Gautreau A (2014) Steering cell migration: lamellipodium dynamics and the regulation of directional persistence. Nat Rev Mol Cell Biol 15:577-590.
71. Kraynov VS, Chamberlain C, Bokoch GM, Schwartz MA, Slabaugh S, and Hahn KM (2000) Localized Rac activation dynamics visualized in living cells. Science 290: 333-337.
72. Kumar R, Gururaj AE, and Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6:459-471.
73. Kuo JC, Han X, Hsiao CT, Yates JR 3rd, and Waterman CM (2011) Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for b-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol 13:383-393.
74. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-189.
75. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, et al. (2009) Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 29:480-487.
76. Li T, Yang G, Xu J, Zhu Y, and Liu L (2011) Regulatory effect of Rac1 on vascular reactivity after hemorrhagic shock in rats. J Cardiovasc Pharmacol 57:656-665.
77. Libby P (2006) Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 98 (12A):3Q-9Q.
78. Liu S, Kapoor M, and Leask A (2009) Rac1 expression by fibroblasts is required for tissue repair in vivo. Am J Pathol 174:1847-1856.
79. Liu Y, Collins C, Kiosses WB, Murray AM, Joshi M, Shepherd TR, Fuentes EJ, and Tzima E (2013) A novel pathway spatiotemporally activates Rac1 and redox signaling in response to fluid shear stress. J Cell Biol 201:863-873.
80. Liu Z, Vong QP, Liu C, and Zheng Y (2014) Borg5 is required for angiogenesis by regulating persistent directional migration of the cardiac microvascular endothelial cells. Mol Biol Cell 25:841-851.
81. Loirand G and Pacaud P (2010) The role of Rho protein signaling in hypertension. Nat Rev Cardiol 7:637-647.
82. Loirand G and Pacaud P (2014) Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension. Small GTPases 5:1-10.
83. Ma J, Xue Y, Liu W, Yue C, Bi F, Xu J, Zhang J, Li Y, Zhong C, and Chen Y (2013) Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer. PLoS ONE 8:e66275.
84. Maharjan S, Kim K, Agrawal V, Choi HJ, KimNJ, Kim YM, Suh YG, and Kwon YG (2013) Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway. Biochem Biophys Res Commun 435:420-427.
85. Majumder S, Sowden MP, Gerber SA, Thomas T, Christie CK, Mohan A, Yin G, Lord EM, Berk BC, and Pang J (2014) G-protein-coupled receptor-2-interacting protein- 1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formation. Arterioscler Thromb Vasc Biol 34: 419-426.
86. Marchese ME, Berdnikovs S, and Cook-Mills JM (2012) Distinct sites within the vascular cell adhesion molecule-1 (VCAM-1) cytoplasmic domain regulate VCAM-1 activation of calcium fluxes versus Rac1 during leukocyte transendothelial migration. Biochemistry 51:8235-8246.
87. Marinkovic G, Hibender S, Hoogenboezem M, van Broekhoven A, Girigorie AF, Bleeker N, Hamers AA, Stap J, van Buul JD, de Vries CJ, et al. (2013) Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 33:2380-2388.
88. Marinković G, Hamers AA, de Vries CJ, and de Waard V (2014a) 6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1. Inflamm Bowel Dis 20:1487-1495.
89. Marinković G, Kroon J, Hoogenboezem M, Hoeben KA, Ruiter MS, Kurakula K, Otermin Rubio I, Vos M, de Vries CJ, van Buul JD, et al. (2014b) Inhibition of GTPase Rac1 in endothelium by 6-mercaptopurine results in immunosuppression in nonimmune cells: new target for an old drug. J Immunol 192:4370-4378.
90. Martinelli R, Kamei M, Sage PT, Massol R, Varghese L, Sciuto T, Toporsian M, Dvorak AM, Kirchhausen T, Springer TA, et al. (2013) Release of cellular tension signals self-restorative ventral lamellipodia to heal barrier micro-wounds. J Cell Biol 201:449-465.
91. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG (2006) Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18:69-82.
92. Mayor R and Carmona-Fontaine C (2010) Keeping in touch with contact inhibition of locomotion. Trends Cell Biol 20:319-328.
93. Meng D, Lv DD, and Fang J (2008) Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc Res 80:299-308.
94. Moldovan L, Mythreye K, Goldschmidt-Clermont PJ, and Satterwhite LL (2006) Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1. Cardiovasc Res 71:236-246.
95. Monaghan-Benson E and Burridge K (2009) The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284:25602-25611.
96. Nagase M (2013) Role of Rac1 GTPase in salt-sensitive hypertension. Curr Opin Nephrol Hypertens 22:148-155.
97. Ng CK, Deshpande SS, Irani K, and Alevriadou BR (2002) Adhesion of flowing monocytes to hypoxia-reoxygenation-exposed endothelial cells: Role of Rac1, ROS, and VCAM-1. Am J Physiol Cell Physiol 283:C93-C102.
98. Nimnual AS, Taylor LJ, and Bar-Sagi D (2003) Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 5:236-241.
99. Ohta Y, Hartwig JH, and Stossel TP (2006) FilGAP, a Rho- And ROCK-regulated GAP for Rac binds filamin A to control actin remodelling. Nat Cell Biol 8:803-814.
100. Palinski W and Napoli C (2002) Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol 22:1745-1750.
101. Papaharalambus C, Sajjad W, Syed A, Zhang C, Bergo MO, Alexander RW, and Ahmad M(2005) Tumor necrosis factor alpha stimulation of Rac1 activity. Role of isoprenylcysteine carboxylmethyl transferase. J Biol Chem 280:18790-18796.
102. Pescatore LA, Bonatto D, Forti FL, Sadok A, Kovacic H, and Laurindo FR (2012) Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation. J Biol Chem 287:29290-29300.
103. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA, Subramanian V, Poduri A, Charnigo R, Cassis LA, and Daugherty A (2011) Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ Res 108:574-581.
104. Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M, and Santiemma V (2009) Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation. Atherosclerosis 203:97-104.
105. Rozycki M, Lodyga M, Lam J, Miranda MZ, Fátyol K, Speight P, and Kapus A (2014) The fate of the primary cilium during myofibroblast transition. Mol Biol Cell 25: 643-657.
106. Rüegg C and Mariotti A (2003) Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 60: 1135-1157.
107. Schmidt TT, Tauseef M, Yue L, Bonini MG, Gothert J, Shen TL, Guan JL, Predescu S, Sadikot R, and Mehta D (2013) Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to destabilization of RhoA and Rac1 activities. Am J Physiol Lung Cell Mol Physiol 305:L291-L300.
108. Schröder K, Helmcke I, Palfi K, Krause KH, Busse R, and Brandes RP (2007) Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27:1736-1743.
109. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, et al. (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110:1217-1225.
110. Shinde AV and Frangogiannis NG (2014) Fibroblasts in myocardial infarction: A role in inflammation and repair. J Mol Cell Cardiol 70:74-82.
111. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, and Guan KL (2000) Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290:144-147.
112. Singleton PA, Dudek SM, Ma SF, and Garcia JG (2006) Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 281:34381-34393.
113. Streeter J, Thiel W, Brieger K, and Miller FJ Jr (2013) Opportunity nox: The future of NADPH oxidases as therapeutic targets in cardiovascular disease. Cardiovasc Ther 31:125-137.
114. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, et al. (2006) Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290:L661-L673.
115. Sumimoto H (2008) Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 275:3249-3277.
116. Sun J, Yang T, Wang P, Ma S, Zhu Z, Pu Y, Li L, Zhao Y, Xiong S, Liu D, et al. (2014) Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathway. Hypertension 63:1354-1363.
117. Taglieri DM, Ushio-Fukai M, and Monasky MM (2014) P21-activated kinase in inflammatory and cardiovascular disease. Cell Signal 26:2060-2069.
118. Tan W, Palmby TR, Gavard J, Amornphimoltham P, Zheng Y, and Gutkind JS (2008) An essential role for Rac1 in endothelial cell function and vascular development. FASEB J 22:1829-1838.
119. Tanaka S, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, Takai Y, Williams CL, Liao JK, and Shimokawa H (2013) Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol 33:1591-1600.
120. Teng TS, Lin B, Manser E, Ng DC, and Cao X (2009) Stat3 promotes directional cell migration by regulating Rac1 activity via its activator betaPIX. J Cell Sci 122: 4150-4159.
121. Tieu BC, Ju X, Lee C, Sun H, Lejeune W, Recinos A 3rd, Brasier AR, and Tilton RG (2011) Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling. J Vasc Res 48:261-272.
122. Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, and van Buul JD (2012) The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of b-catenin phosphorylation. Mol Biol Cell 23: 4212-4225.
123. Tsai CT, Lai LP, Kuo KT, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Tseng YZ, Chiang FT, and Lin JL (2008) Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 117: 344-355.
124. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, et al. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994.
125. Van Buul JD, Fernandez-Borja M, Anthony EC, and Hordijk PL (2005) Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7:308-317.
126. van Buul JD, Allingham MJ, Samson T, Meller J, Boulter E, García-Mata R, and Burridge K (2007) RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte trans-endothelial migration. J Cell Biol 178:1279-1293.
127. van Hooren KW, Spijkers LJ, van Breevoort D, Fernandez-Borja M, Bierings R, van Buul JD, Alewijnse AE, Peters SL, and Voorberg J (2014) Sphingosine-1-phosphate receptor 3 mediates sphingosine-1-phosphate induced release of weibel-palade bodies from endothelial cells. PLoS ONE 9:e91346.
128. van Rijssel J, Hoogenboezem M, Wester L, Hordijk PL, and van Buul JD (2012a) The N-terminal DH-PH domain of Trio induces cell spreading and migration by regulating lamellipodia dynamics in a Rac1-dependent fashion. PLoS One 7:e29912.
129. van Rijssel J, Kroon J, Hoogenboezem M, van Alphen FP, de Jong RJ, Kostadinova E, Geerts D, Hordijk PL, and van Buul JD (2012b) The Rho-guanine nucleotide exchange factor Trio controls leukocyte transendothelial migration by promoting docking structure formation. Mol Biol Cell 23:2831-2844.
130. van Rijssel J, Timmerman I, van Alphen FP, Hoogenboezem M, Korchynskyi O, Geerts D, Geissler J, Reedquist KA, Niessen HW, and van Buul JD (2013) The Rho- GEF Trio regulates a novel pro-inflammatory pathway through the transcription factor Ets2. Biol Open 2:569-579.
131. van Wetering S, van Buul JD, Quik S, Mul FP, Anthony EC, ten Klooster JP, Collard JG, and Hordijk PL (2002) Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 115:1837-1846.
132. Varela LM, Bermúdez B, Ortega-Gómez A, López S, Sánchez R, Villar J, Anguille C, Muriana FJ, Roux P, and Abia R (2014) Postprandial triglyceride-rich lipoproteins promote invasion of human coronary artery smooth muscle cells in a fatty-acid manner through PI3k-Rac1-JNK signaling. Mol Nutr Food Res 58:1349-1364.
133. Wang D, Paria BC, Zhang Q, Karpurapu M, Li Q, Gerthoffer WT, Nakaoka Y, and Rao GN (2009) A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis. Circ Res 104:1066-1075.
134. Wang F, Yamauchi M, Muramatsu M, Osawa T, Tsuchida R, and Shibuya M (2011a) RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway. J Biol Chem 286:9097-9106.
135. Wang Y, Zang QS, Liu Z, Wu Q, Maass D, Dulan G, Shaul PW, Melito L, Frantz DE, Kilgore JA, et al. (2011b) Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am J Physiol Cell Physiol 301:C695-C704.
136. Waschke J, Burger S, Curry FR, Drenckhahn D, and Adamson RH (2006) Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier. Histochem Cell Biol 125:397-406.
137. Wu JH, Fanaroff AC, Sharma KC, Smith LS, Brian L, Eipper BA, Mains RE, Freedman NJ, and Zhang L (2013a) Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells. Arterioscler Thromb Vasc Biol 33:702-708.
138. Wu K, Tian S, Zhou H, and Wu Y (2013b) Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochem Pharmacol 85: 1753-1760.
139. Xuan YH, Huang BB, Tian HS, Chi LS, Duan YM, Wang X, Zhu ZX, Cai WH, Zhu YT, Wei TM, et al. (2014) High-glucose inhibits human fibroblast cell migration in wound healing via repression of bFGF-regulating JNK phosphorylation. PLoS ONE 9:e108182.
140. Yeh LH, Park YJ, Hansalia RJ, Ahmed IS, Deshpande SS, Goldschmidt-Clermont PJ, Irani K, and Alevriadou BR (1999) Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. Am J Physiol 276:C838-C847.
141. Zimmerman MC, Takapoo M, Jagadeesha DK, Stanic B, Banfi B, Bhalla RC, and Miller FJ Jr (2011) Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells. Hypertension 58:446-453.
142. Zuckerbraun BS, Barbato JE, Hamilton A, Sebti S, and Tzeng E (2005) Inhibition of geranylgeranyltransferase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production. J Surg Res 124:256-263.